Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

151 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The Value of Multidisciplinary Neuro-oncological Tumor Boards to Increase the Accuracy of FET PET for Identifying Brain Tumor Relapse.
Ceccon GS, Werner JM, Ruge MI, Goldbrunner R, Celik E, Baues C, Deckert M, Brunn A, Rongen MM, Büttner R, Dunkl V, Nogova L, Schlamann M, Kabbasch C, Rueß D, Hampl J, Wollring MM, Rosen EK, Tscherpel C, Stoffels G, Lohmann P, Mottaghy FM, Fink GR, Langen KJ, Galldiks N. Ceccon GS, et al. Among authors: lohmann p. Clin Nucl Med. 2025 Jan 14. doi: 10.1097/RLU.0000000000005634. Online ahead of print. Clin Nucl Med. 2025. PMID: 39806562
Revealing novel protein interaction partners of glyphosate in Escherichia coli.
Aldehoff AS, Türkowsky D, Lohmann P, Homsi MN, Rolle-Kampczyk U, Ueberham E, Lehmann J, Bergen MV, Jehmlich N, Haange SB. Aldehoff AS, et al. Among authors: lohmann p. Environ Int. 2024 Dec 25;195:109243. doi: 10.1016/j.envint.2024.109243. Online ahead of print. Environ Int. 2024. PMID: 39733591 Free article.
Artificial Intelligence for Response Assessment in Neuro Oncology (AI-RANO), part 2: recommendations for standardisation, validation, and good clinical practice.
Bakas S, Vollmuth P, Galldiks N, Booth TC, Aerts HJWL, Bi WL, Wiestler B, Tiwari P, Pati S, Baid U, Calabrese E, Lohmann P, Nowosielski M, Jain R, Colen R, Ismail M, Rasool G, Lupo JM, Akbari H, Tonn JC, Macdonald D, Vogelbaum M, Chang SM, Davatzikos C, Villanueva-Meyer JE, Huang RY; Response Assessment in Neuro Oncology (RANO) group. Bakas S, et al. Among authors: lohmann p. Lancet Oncol. 2024 Nov;25(11):e589-e601. doi: 10.1016/S1470-2045(24)00315-2. Lancet Oncol. 2024. PMID: 39481415 Review.
Artificial Intelligence for Response Assessment in Neuro Oncology (AI-RANO), part 1: review of current advancements.
Villanueva-Meyer JE, Bakas S, Tiwari P, Lupo JM, Calabrese E, Davatzikos C, Bi WL, Ismail M, Akbari H, Lohmann P, Booth TC, Wiestler B, Aerts HJWL, Rasool G, Tonn JC, Nowosielski M, Jain R, Colen RR, Pati S, Baid U, Vollmuth P, Macdonald D, Vogelbaum MA, Chang SM, Huang RY, Galldiks N; Response Assessment in Neuro Oncology (RANO) group. Villanueva-Meyer JE, et al. Among authors: lohmann p. Lancet Oncol. 2024 Nov;25(11):e581-e588. doi: 10.1016/S1470-2045(24)00316-4. Lancet Oncol. 2024. PMID: 39481414 Review.
Multicentric 68Ga-PSMA PET radiomics for treatment response assessment of 177Lu-PSMA-617 radioligand therapy in patients with metastatic castration-resistant prostate cancer.
Gutsche R, Gülmüs G, Mottaghy FM, Gärtner F, Essler M, von Mallek D, Ahmadzadehfar H, Lohmann P, Heinzel A. Gutsche R, et al. Among authors: lohmann p. Front Nucl Med. 2023 Sep 14;3:1234853. doi: 10.3389/fnume.2023.1234853. eCollection 2023. Front Nucl Med. 2023. PMID: 39355016 Free PMC article.
PET imaging of gliomas: Status quo and quo vadis?
Galldiks N, Lohmann P, Friedrich M, Werner JM, Stetter I, Wollring MM, Ceccon G, Stegmayr C, Krause S, Fink GR, Law I, Langen KJ, Tonn JC. Galldiks N, et al. Among authors: lohmann p. Neuro Oncol. 2024 Dec 9;26(Supplement_9):S185-S198. doi: 10.1093/neuonc/noae078. Neuro Oncol. 2024. PMID: 38970818 Review.
151 results